TELETRADER News
5/7, 1:17 PM (Source: TeleTrader)
more TeleTrader news

UK's JCVI: Under-40's should get alternative to AZ jab

The United Kingdom Joint Committee on Vaccination and Immunisation (JCVI) released on Friday a recommendation for the UK government to provide people without underlying health conditions aged 18 to 39 an alternative to the AstraZeneca vaccine when possible due to the risk of extremely rare blood clots associated with the jab.

Low serious infection risk rates for younger individuals due to the improving COVID situation in the country and an improving vaccine portfolio were cited as the reasons for the new guidelines. Those who already got an AstraZeneca shot as their first dose with no adverse effects should be revaccinated with the same vaccine regardless of age according to JCVI.

"Safety remains our number one priority," said COVID-19 Chair for JCVI Professor Wei Shen Lim. The advice comes after the British Medicines and Healthcare Products Regulatory Agency (MHRA) made the same recommendation for people under 30 last month.

Breaking the News / MJ